110 related articles for article (PubMed ID: 2014582)
1. [Chemotherapy of prostatic carcinoma].
Wirth M; Altwein JE
Urologe A; 1991 Jan; 30(1):17-24. PubMed ID: 2014582
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of advanced cancer of the prostate.
Wirth MP
Prog Clin Biol Res; 1990; 350():159-70. PubMed ID: 2201042
[No Abstract] [Full Text] [Related]
3. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
4. New standards in the chemotherapy of metastatic hormone-refractory prostate cancer.
Sava T; Basso U; Porcaro A; Cetto GL
Expert Rev Anticancer Ther; 2005 Feb; 5(1):53-62. PubMed ID: 15757438
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy in prostatic carcinoma].
Pérez Manga G; Arranz Arija JA; García Gómez R; Salinas Hernández P; González del Val R
Arch Esp Urol; 1993 Mar; 46(2):116-26. PubMed ID: 8498851
[TBL] [Abstract][Full Text] [Related]
6. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
[TBL] [Abstract][Full Text] [Related]
7. [Advanced prostate cancer--a therapeutic dilemma?].
Rübben H; Altwein JE
Urologe A; 1987 Jan; 26(1):7-14. PubMed ID: 3576864
[TBL] [Abstract][Full Text] [Related]
8. [Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate].
Matveev BP; Bukharkin BV
Vopr Onkol; 1998; 44(5):537-40. PubMed ID: 9884710
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer chemotherapy: emerging from the shadows.
Roth BJ
J Clin Oncol; 2005 May; 23(15):3302-3. PubMed ID: 15738529
[No Abstract] [Full Text] [Related]
10. [Chemotherapy of hormone-unresponsive prostatic cancer and its metastatic foci].
Kotake T
Gan To Kagaku Ryoho; 1982 Mar; 9(3):387-96. PubMed ID: 6764105
[TBL] [Abstract][Full Text] [Related]
11. How effective is cytotoxic chemotherapy for disseminated prostatic carcinoma?
Eisenberger MA; Kennedy P; Abrams J
Oncology (Williston Park); 1987 Jun; 1(4):59-71. PubMed ID: 3079482
[TBL] [Abstract][Full Text] [Related]
12. Intermittent chemotherapy for metastatic hormone refractory prostate cancer.
Lin AM; Ryan CJ; Small EJ
Crit Rev Oncol Hematol; 2007 Mar; 61(3):243-54. PubMed ID: 17161610
[TBL] [Abstract][Full Text] [Related]
13. [Primary chemotherapy in operable breast carcinoma].
Bonadonna G; Valagussa P
Ann Ital Chir; 1999; 70(3):359-69. PubMed ID: 10466239
[TBL] [Abstract][Full Text] [Related]
14. [Combination hormone-chemotherapy versus hormone therapy alone in the initial treatment of advanced prostate carcinoma--a prospective cooperative study].
Gorski J; Böhm WD; Illig HD; Koch R
Urologe A; 1988 Sep; 27(5):287-90. PubMed ID: 3051628
[TBL] [Abstract][Full Text] [Related]
15. Weekly chemotherapeutic regimen in metastatic prostate cancer.
Burk K
Prog Clin Biol Res; 1990; 350():187-200. PubMed ID: 2201043
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of bicalutamide in adjuvant treatment of prostatic carcinoma after primary therapy with curative aim. The viewpoint of the surgeon].
Rigatti P; Scattoni V
Recenti Prog Med; 2002 Mar; 93(3):183-5. PubMed ID: 11942171
[No Abstract] [Full Text] [Related]
17. Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study.
Bracarda S; Tonato M; Rosi P; De Angelis V; Mearini E; Cesaroni S; Fornetti P; Porena M
Cancer; 2000 Mar; 88(6):1438-44. PubMed ID: 10717628
[TBL] [Abstract][Full Text] [Related]
18. Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number-needed-to-treat analysis.
Jani AB; Kao J; Hellman S
Cancer; 2003 Dec; 98(11):2351-61. PubMed ID: 14635069
[TBL] [Abstract][Full Text] [Related]
19. [The study landscape for prostate cancer].
Miller K
Urologe A; 2005 Dec; 44(12):1431-4. PubMed ID: 16292461
[TBL] [Abstract][Full Text] [Related]
20. Prostate specific antigen response to mitoxantrone and prednisone in patients with refractory prostate cancer: prognostic factors and generalizability of a multicenter trial to clinical practice.
Dowling AJ; Czaykowski PM; Krahn MD; Moore MJ; Tannock IF
J Urol; 2000 May; 163(5):1481-5. PubMed ID: 10751862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
